Kyntra Bio
KYNB
225 hedge funds and large institutions have $3.15B invested in Kyntra Bio in 2019 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 76 increasing their positions, 72 reducing their positions, and 15 closing their positions.
160% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 15
20% more capital invested
Capital invested by funds: $2.63B → $3.15B (+$523M)
12% more funds holding
Funds holding: 201 → 225 (+24)
6% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 72
0.04% more ownership
Funds ownership: 2.67% → 2.71% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
75% less call options, than puts
Call options by funds: $43.5M | Put options by funds: $175M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$34.1M |
| 2 |
Janus Henderson Group
London,
|
+$25.7M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$18.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$17.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$73.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.1M |
| 3 |
D.E. Shaw & Co
New York
|
-$7.58M |
| 4 |
BlackRock
New York
|
-$7.4M |
| 5 |
Citigroup
New York
|
-$7.31M |
KYNB Hedge Fund Activity: Q1 2019 in Review
225 of the 4,632 institutional investors tracked by Wall St. Rank reported a position in Kyntra Bio (KYNB) for Q1 2019, worth a combined $3.15B — up 20% from $2.63B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new KYNB positions and 15 closed out — a net gain of 24 holders — while 76 added to existing stakes and 72 trimmed.
The largest buyer was Fiera Capital (Canada), opening a new position worth an estimated $34.1M. The largest seller was EcoR1 Capital, cutting an estimated $73.6M.
- 225 institutional investors held Kyntra Bio (KYNB) as of Q1 2019, up from 201 in Q4 2018.
- Funds reported $3.15B of Kyntra Bio stock for Q1 2019, up 20% quarter-over-quarter.
- 39 funds opened new Kyntra Bio positions in Q1 2019 and 15 closed out, a net change of +24 holders.
- The largest Kyntra Bio buyer in Q1 2019 was Fiera Capital (Canada), an estimated $34.1M added.
- The largest Kyntra Bio seller in Q1 2019 was EcoR1 Capital, an estimated $73.6M sold.
Based on aggregated 13F filings for Q1 2019.